A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever

NCT04906980 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Feasibility of enrollment impacted by COVID

Conditions

Dengue

Interventions

DRUG: JNJ-64281802
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC